Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 2 (RPL31P2)

Target: RPL31P2
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L31 pseudogene 2 (RPL31P2) is a processed pseudogene in the human genome related to the RPL31 gene, which encodes a structural component of the 60S ribosomal subunit. Pseudogenes like RPL31P2 arise by retrotransposition and do not produce functional proteins; while the parent RPL31 gene is involved in protein synthesis and cell growth, RPL31P2 does not serve any known biological function, is not a therapeutic target, and is classified as a noncoding pseudogene[7][5].

Other names: dJ553F4.5RPL31_25_1695RPL31P2

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 2 (RPL31P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 2 (RPL31P2).

Explore the full profile